Roche Cobas Blood Screening Test Gets FDA OK | GenomeWeb

NEW YORK (GenomeWeb) – Roche said today that the US Food and Drug Administration has approved the cobas TaqScreen MPX Test v2.0 for blood screening.

The real-time, multi-dye PCR assay is designed to detect and identify HIV, hepatitis B virus, and hepatitis C virus in donations of human whole blood and blood components including source plasma. It runs on the company's fully automated cobas s 201 system, which uses four separate channels for signal detection, enabling simultaneous monitoring of the three viral targets and an internal control.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.